250 related articles for article (PubMed ID: 16410815)
1. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
[TBL] [Abstract][Full Text] [Related]
2. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
4. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
5. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
8. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
9. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
[TBL] [Abstract][Full Text] [Related]
12. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
14. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
15. The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections.
Hsu WM; Chiou SH; Chen SS; Shyong MP; Ho CK; Chen SJ; Wu CC; Kung SH; Chi CW
Ophthalmologica; 2004; 218(5):328-32. PubMed ID: 15334014
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
Tangsinmankong N; Kamchaisatian W; Lujan-Zilbermann J; Brown CL; Sleasman JW; Emmanuel PJ
J Allergy Clin Immunol; 2004 Apr; 113(4):742-6. PubMed ID: 15100682
[TBL] [Abstract][Full Text] [Related]
19. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
20. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
